SEC Filing Details
Document Details
Form
Filing Date
October 19, 2022
Document Date
October 17, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
RA CAPITAL MANAGEMENT, L.P.